The Role of Semaglutide in Weight Management: An Analysis of Clinical Studies for Overweight and Obese Adults
Bibliographic record
Abstract
Obesity is a mounting global health challenge, and recent advancements in pharmacologic interventions have brought new hope to this complex issue. One such intervention, semaglutide, marketed as Ozempic and Wegovy, has shown promising results in weight management among adults with overweight or obesity. This paper synthesizes findings from key clinical studies to evaluate the efficacy, safety, and long-term impact of semaglutide in weight management. Semaglutide, initially developed for type 2 diabetes management, functions by mimicking the human glucagon-like peptide-1, thereby reducing appetite and food intake. Regulatory bodies in the United States, Europe, the United Kingdom, and Canada have approved its use for weight mana gement at a weekly dose of 2.4 mg, marking a significant step in obesity treatment. Alongside its benefits, the paper also addresses the safety profile and adverse effects associated with semaglutide. While generally well-tolerated, rare but serious adverse effects have been reported, necessitating a careful assessment of risks and benefits in clinical practice. In conclusion, semaglutide presents a significant advancement in the pharmacologic management of obesity. Its ability to induce considerable weight loss, coupled with improvements in cardiovascular and metabolic health, positions it as a promising tool in the arsenal against obesity. Future research should focus on long-term efficacy, safety, and the integration of comprehensive lifestyle interventions to optimize treatment outcomes.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".